Practice question

Answer the question and get instant feedback.

MediumEndocrinologyType 2 diabetes with cardiovascular riskau-amcau-racp

A 58-year-old man with type 2 diabetes and hypertension has an HbA1c of 7.8 percent on metformin and lifestyle measures. His eGFR is 70 mL/min/1.73 m2 and urine albumin-creatinine ratio is 12 mg/mmol. According to contemporary Australian diabetes guidance, which additional pharmacological agent provides both glycaemic and cardiovascular benefit?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.